The Biotech Trader Handbook, from the original edition through the Sub-Sector Series.
Published 2010. Where the framework started.
T. Ayers Pelz — the book that started it all. A fast, simplified guide to identifying, analyzing, and structuring options trades around small-cap biotech catalysts.
View on AmazonDeep dives into a single emerging area, published outside the numbered series.
Psychedelics, ketamine, digital therapeutics, and breakthrough CNS treatments — a focused application of the MoA/Path framework to one of biotech's fastest-moving niches.
View on AmazonEight sub-sectors, each with its own Path Tool, MoA Tool, Catalyst Stack, and Trade Setups. Six are live now — two more are finished and releasing shortly.
Read in any order — each book covers a different sub-sector on its own; the series isn't cumulative.
Editions of the Biotech Trader Handbook in German, Italian, Portuguese and Japanese.
